Showing Results for
- Academic Journals (38)
Search Results
- 38
Academic Journals
- 38
- Search Terms:
- 1From: Diabetology & Metabolic Syndrome. (Vol. 4, Issue 1) Peer-ReviewedBackground The prevalence and magnitude of obesity in the children and the adolescents have increased dramatically in the developing countries over the last 20-30 years. The prevalence of metabolic syndrome (MS) in...
- 2From: Diabetology & Metabolic Syndrome. (Vol. 4, Issue 1) Peer-ReviewedBackground The incidence of type 2 diabetes mellitus (T2DM) has been increasing in recent years. Sleep loss and circadian rhythm abnormalities are thought to be one of the underlying causes of adverse metabolic...
- 3From: Diabetology & Metabolic Syndrome. (Vol. 4, Issue 1) Peer-ReviewedBackground To ascertain whether the associations between obesity, inflammation, and insulin resistance established in human adult studies are found among adolescents. Methods We contrasted 36 obese and 24 lean...
- 4From: Diabetology & Metabolic Syndrome. (Vol. 4, Issue 1) Peer-ReviewedIn recent decades, metabolic syndrome has become a public health problem throughout the world. Longitudinal studies in humans have several limitations due to the invasive nature of certain analyses and the size and...
- 5From: Diabetology & Metabolic Syndrome. (Vol. 4, Issue 1) Peer-ReviewedBackground Available definition criteria for metabolic syndrome (MS) have similarities and inconsistencies. The aim of this study was to determine the prevalence of MS in a group of Cameroonians with type 2 diabetes,...
- 6From: Diabetology & Metabolic Syndrome. (Vol. 4, Issue 1) Peer-ReviewedMetabolic Syndrome (MetS) is associated with increased risk of morbi-mortality, thus the characterization of the population magnitude of this syndrome is critical for allocating health care. However, prevalence...
- 7From: Diabetology & Metabolic Syndrome. (Vol. 4, Issue 1) Peer-ReviewedBackground Omentin is an adipocytokine that is abundantly expressed in visceral fat tissue. We investigated the association of omentin with the number of metabolic risk factors. Finding The study population...
- 8From: Diabetology & Metabolic Syndrome. (Vol. 4, Issue 1) Peer-ReviewedBackground Achieving good glycemic control is of paramount importance in the reduction of diabetes mellitus (DM) associated morbidity and mortality. Insulin plays a key role in the management of DM but unfortunately...
- 9From: Diabetology & Metabolic Syndrome. (Vol. 4, Issue 1) Peer-ReviewedBackground Individuals with diabetes who are smokers have higher risks of cardiovascular disease, premature death, and microvascular complications. The present study aims to determine the prevalence of symptoms of...
- 10From: Diabetology & Metabolic Syndrome. (Vol. 4, Issue 1) Peer-ReviewedBackground Frequent consumption of a diet high in fat and sucrose contributes to lifestyle-related diseases. However, limited information is available regarding the short-term effects of such a diet on the onset of...
- 11From: Diabetology & Metabolic Syndrome. (Vol. 4, Issue 1) Peer-ReviewedThe number of people with diabetes and pre-diabetes are exponentially increasing. Studies on humans have shown the beneficial effects of Zinc supplementation in patients with diabetes. The present study aims to...
- 12From: Diabetology & Metabolic Syndrome. (Vol. 4, Issue 1) Peer-ReviewedBackground Familial partial lipodystrophies (FPLD) are clinically heterogeneous disorders characterized by selective loss of adipose tissue, insulin resistance and metabolic complications. Until genetic studies...
- 13From: Diabetology & Metabolic Syndrome. (Vol. 4, Issue 1) Peer-ReviewedBackground Asymmetric N.sup.G,N.sup.G-dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, is regulated by the enzymatic participants of synthetic and metabolic processes, i.e., type I protein...
- 14From: Diabetology & Metabolic Syndrome. (Vol. 4, Issue 1) Peer-ReviewedBackground Previous studies have reported that microalbuminuria is an independent risk factor for the prevalence of diabetic retinopathy (DR) in patients with type 2 diabetes mellitus (DM). For this reason, the...
- 15From: Diabetology & Metabolic Syndrome. (Vol. 4, Issue 1) Peer-ReviewedBackground Environmental conditions in early life can induce permanent physiological changes, sometimes increasing the risk of chronic diseases during adulthood. Neural and peripheral circuits controlling energy...
- 16From: Diabetology & Metabolic Syndrome. (Vol. 4, Issue 1) Peer-ReviewedThe advanced glycation end products, namely AGEs, contribute to long-termed complications of diabetes mellitus, including macroangiopathy, where smooth muscle cells (SMC) proliferation stimulated by platelet-derived...
- 17From: Diabetology & Metabolic Syndrome. (Vol. 4, Issue 1) Peer-ReviewedBackground Diabetes mellitus type 1 is an autoimmune disorder caused by lymphocytic infiltration and beta cells destruction. Curcumin has been identified as a potent inducer of heme-oxygenase-1 (HO-1), a...
- 18From: Diabetology & Metabolic Syndrome. (Vol. 4, Issue 1) Peer-ReviewedMetabolic Syndrome (MS) increases the risk for Coronary Artery Disease, stroke and diabetes. MS is twice more common amongst South Asian immigrants in US compared to native Caucasians. There are no nationally...
- 19From: Diabetology & Metabolic Syndrome. (Vol. 4, Issue 1) Peer-ReviewedBackround To evaluate the importance of oral glucose tolerance test (OGTT) in predicting diabetes and cardiovascular disease in patients with and without Metabolic Syndrome from a population treated in a primary care...
- 20From: Diabetology & Metabolic Syndrome. (Vol. 4, Issue 1) Peer-ReviewedBackground Obesity contributes to Type 2 diabetes by promoting systemic insulin resistance. Obesity causes features of metabolic dysfunction in the adipose tissue that may contribute to later impairments of insulin...